| Market Cap | 2.66B | P/E | 187.50 | EPS this Y | -60.70% | Ern Qtrly Grth | - |
| Income | -215.5M | Forward P/E | - | EPS next Y | 141.80% | 50D Avg Chg | -9.00% |
| Sales | 3.01B | PEG | -4.06 | EPS past 5Y | - | 200D Avg Chg | -9.00% |
| Dividend | N/A | Price/Book | EPS next 5Y | -8.80% | 52W High Chg | -20.00% | |
| Recommedations | 2.70 | Quick Ratio | 1.02 | Shares Outstanding | 89.60M | 52W Low Chg | 1.00% |
| Insider Own | 0.28% | ROA | -0.59% | Shares Float | 74.45M | Beta | - |
| Inst Own | 115.67% | ROE | -13.42% | Shares Shorted/Prior | 7.37M/6.67M | Price | 30.00 |
| Gross Margin | 15.15% | Profit Margin | -9.49% | Avg. Volume | 2,714,674 | Target Price | 23.70 |
| Oper. Margin | -6.11% | Earnings Date | Nov 11 | Volume | 1,554,060 | Change | -2.63% |
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
| Jefferies | Hold | Sep 25, 24 |
| William Blair | Market Perform | Sep 11, 24 |
| Deutsche Bank | Hold | Aug 20, 24 |
| TD Cowen | Hold | Aug 13, 24 |
| B of A Securities | Underperform | Aug 13, 24 |
| Citigroup | Buy | Aug 13, 24 |
| Barclays | Equal-Weight | Aug 13, 24 |
| Evercore ISI Group | In-Line | Aug 13, 24 |
| Baird | Outperform | Aug 13, 24 |